Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3VG9

Crystal structure of human adenosine A2A receptor with an allosteric inverse-agonist antibody at 2.7 A resolution

Summary for 3VG9
Entry DOI10.2210/pdb3vg9/pdb
Related3VGA
DescriptorAdenosine receptor A2a, antibody fab fragment light chain, antibody fab fragment heavy chain, ... (7 entities in total)
Functional Keywords7 transmembrane receptor, signal transduction, signaling protein
Biological sourceHomo sapiens (human)
More
Cellular locationCell membrane; Multi-pass membrane protein: P29274
Total number of polymer chains3
Total formula weight86917.91
Authors
Primary citationHino, T.,Arakawa, T.,Iwanari, H.,Yurugi-Kobayashi, T.,Ikeda-Suno, C.,Nakada-Nakura, Y.,Kusano-Arai, O.,Weyand, S.,Shimamura, T.,Nomura, N.,Cameron, A.D.,Kobayashi, T.,Hamakubo, T.,Iwata, S.,Murata, T.
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
Nature, 482:237-240, 2012
Cited by
PubMed Abstract: G-protein-coupled receptors are the largest class of cell-surface receptors, and these membrane proteins exist in equilibrium between inactive and active states. Conformational changes induced by extracellular ligands binding to G-protein-coupled receptors result in a cellular response through the activation of G proteins. The A(2A) adenosine receptor (A(2A)AR) is responsible for regulating blood flow to the cardiac muscle and is important in the regulation of glutamate and dopamine release in the brain. Here we report the raising of a mouse monoclonal antibody against human A(2A)AR that prevents agonist but not antagonist binding to the extracellular ligand-binding pocket, and describe the structure of A(2A)AR in complex with the antibody Fab fragment (Fab2838). This structure reveals that Fab2838 recognizes the intracellular surface of A(2A)AR and that its complementarity-determining region, CDR-H3, penetrates into the receptor. CDR-H3 is located in a similar position to the G-protein carboxy-terminal fragment in the active opsin structure and to CDR-3 of the nanobody in the active β(2)-adrenergic receptor structure, but locks A(2A)AR in an inactive conformation. These results suggest a new strategy to modulate the activity of G-protein-coupled receptors.
PubMed: 22286059
DOI: 10.1038/nature10750
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon